| Ident. | Authors (with country if any) | Title |
|---|
| 000045 (1983) |
W. Danielczyk [Autriche] | Various mental behavioral disorders in Parkinson's disease, primary degenerative senile dementia, and multiple infarction dementia |
| 000068 (1986) |
G. Ransmayr ; W. Poewe ; S. Plörer ; F. Gerstenbrand ; K. Leidlmair [Autriche] ; U. Mayr | Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters |
| 000070 (1982) |
Kurt Jellinger [Autriche] | Adjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085 |
| 000081 (2010) |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 000085 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000089 (2009) |
Werner Poewe [Autriche] | Clinical measures of progression in Parkinson's disease |
| 000096 (1993) |
G. Heinz [Autriche] ; G. Kreiner [Autriche] ; S. Radosztics [Autriche] ; P. Siostrzonek [Autriche] ; H. Gössinger [Autriche] | Management of elderly patients with the Wolff-Parkinson-White syndrome: is less aggressive treatment justified? |
| 000116 (1999) |
Franz Gerstenbrand [Autriche] ; Elisabeth Karamat [Autriche] | Adolf Hitler's Parkinson's disease and an attempt to analyse his personality structure |
| 000130 (2011) |
Josef Finsterer [Autriche] | Parkinson's syndrome and Parkinson's disease in mitochondrial disorders |
| 000139 (1993) |
E. Fertl [Autriche] ; E. Auff [Autriche] ; A. Doppelbauer [Autriche] ; F. Waldhauser [Autriche] | Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa |
| 000164 (2009) |
A. H. Schapira [Royaume-Uni] ; Y. Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; W. Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
| 000172 (1993) |
G. Arnold [Allemagne] ; B. Bondy [Allemagne] ; O. Bandmann [Allemagne] ; Th. Gasser [Allemagne] ; J. Schwarz [Allemagne] ; C. Trenkwalder [Allemagne] ; M. Wagner [Autriche] ; W. Poewe [Autriche, Allemagne] ; H. Oertel [Allemagne] | 3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes |
| 000177 (1968) |
K. Jellinger [Autriche] ; W. Danielczyk [Autriche] | „Striato-nigrale Degeneration” |
| 000179 (2008) |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000181 (2011) |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
| 000216 (2009) |
Anja Diem-Zangerl [Autriche] ; Klaus Seppi [Autriche] ; Gregor K. Wenning [Autriche] ; Eugen Trinka [Autriche] ; Gerhard Ransmayr [Autriche] ; Wilhelm Oberaigner [Autriche] ; Werner Poewe [Autriche] | Mortality in Parkinson's disease: A 20‐year follow‐up study |
| 000218 (2011) |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations |
| 000227 (1998) |
Poewe [Autriche] ; G. K. Wenning [Autriche] | The natural history of parkinson's disease |
| 000262 (1992) |
H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne] | Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued |
| 000270 (2009) |
Anna Hotter [Autriche] ; Regina Esterhammer [Autriche] ; Michael F. H. Schocke [Autriche] ; Klaus Seppi [Autriche] | Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism |
| 000275 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
